Analytical Data
-
Gene name
RCAD
- Application
-
Alternative Names
CDH4; CAD4; R-CAD; Cadherin 4 Type 1; R-Cadherin
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P55283
-
Expression Region
Leu667~Asp916
-
Molecular Weight
67kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of Recombinant Cell-Adhesive Domain (RCAD) proteins represents a significant advancement in the field of molecular biology and biotechnology, particularly in understanding cell adhesion mechanisms and developing innovative therapeutic approaches. RCAD proteins are engineered to mimic natural cell-adhesive proteins, which play critical roles in cell signaling, tissue regeneration, and wound healing. Their distinctive ability to enhance cell attachment, migration, and differentiation has made them valuable tools in tissue engineering and regenerative medicine. Furthermore, the versatility of RCAD proteins allows for the exploration of their applications in drug delivery systems and cancer therapy, where targeted cell adhesion can improve treatment efficacy and reduce systemic side effects. Given the increasing prevalence of tissue-related diseases and the necessity for improved regenerative strategies, RCAD proteins have emerged as a promising area of research. Ongoing investigations aim to refine their structural properties and optimize their functional capabilities, paving the way for advanced therapeutic solutions and enhanced understanding of cellular interactions within various biological contexts. As researchers unravel the complexities of RCAD protein behavior and interactions at the molecular level, the potential applications in clinical settings become more pronounced, highlighting their importance in future biomedical innovations.
